<DOC>
	<DOCNO>NCT00404859</DOCNO>
	<brief_summary>Background By mean measurement series non-invasive inflammatory marker exhale breath ( condensate ) , reflection inflammatory process oxidative stress , obtain . Thereby , technique could important monitoring asthma CF lung disease child . Fractional exhale nitric oxide ( FeNO ) inflammatory marker exhale breath condensate ( EBC ) reflect ongoing inflammation oxidative stress airway . These marker promise capacity monitoring diagnose CF asthma lung disease . Aim To study course inflammatory marker time child asthma CF , stable period pulmonary exacerbation . In addition , study ability inflammatory marker predict safe taper medical treatment population . 1 . To study course inflammatory marker EBC exacerbation . 2 . To study IM already elevate clinical exacerbation evident predict exacerbation time . 3 . To study inflammatory marker predict safe discontinuation antibiotic child CF , taper inhaled corticosteroid child asthma . 4 . To study relationship inflammatory marker EBC , severity control CF asthma , symptom lung function within patient analyse . Methods Children CF ( n=30 ) child asthma ( n=40 ) recruit included outpatient clinic . During longitudinal study patient visit outpatient clinic followed–up 12 month ; every two month one year . patient visit outpatient clinic . In addition standard visit , During exacerbation patient four extra visit plan exacerbation . ask visit University Hospital Maastricht four time . These additional visit plan maximum two time study . By mean home monitor , child ask assess measurement Besides measurement University Hospital , child measure forced expiratory volume one second ( FEV1 ) home use home monitor , record medication use , , record presence severity pulmonary symptom . Outcome parameter : 1 ) FeNO assessment exhale air , 2 ) inflammatory marker EBC , 3 ) lung function parameter , 4 ) specific questionnaires assess asthma CF control severity , 5 ) data originate home monitor .</brief_summary>
	<brief_title>FLAME : Airway Inflammation Monitoring Asthma Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Asthma define chronic inflammatory disorder , lead recurrent episode wheezing , breathlessness , chest tightness , and/or coughing , base variable airway obstruction [ 18 ] . Children docterdiagnosed asthma know department Paediatric Pulmonology , recruit University Hospital Maastricht . Atopic atopic asthmatic child allow ; treatment inhalation corticosteroïd ( ICS ) oblige . Children known CF recruit University Hospital Maastricht . CF define combination typical clinical feature abnormal sweat test ( Chloride &gt; 60 mM ) . CF lung disease treat accord CBO consensus ref . Main aspect treatment : antibiotic treatment , agent promote airway secretion clearance , DNase , bronchodilator , , physiotherapy . All alternation medical therapy allow accurately document . Diseases may interfere result study ( e.g . upper airway infection , cor vitium , anatomic abnormality airway chronic inflammatory disease , Morbus Crohn rheumatoid arthritis ) , Mental retardation , Inability perform measurement properly , Active smoking , Use follow medication : papaverin , sodium nitroprusside , angiotensinconverting enzyme ( ACE ) inhibitor , oxymetazoline , Larginine , nitric oxide synthase ( NOS ) inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>inflammometry</keyword>
	<keyword>exhale breath condensate</keyword>
	<keyword>fractional exhale nitric oxide</keyword>
	<keyword>asthma</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>monitoring</keyword>
	<keyword>exacerbation</keyword>
	<keyword>paediatric</keyword>
</DOC>